3 months ago
ARDX
AnalystsLaura ChicoLaura Chico's Stock Forecasts
AnalystsLaura Chico
Analyst Ranking
Bottom 6%
#4306 out of 4565 analysts
Average Return
-4.92%
Win Rate
35%36 out of 104
Risk vs Reward
Poor
Good
Laura Chico's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +275.24% | $5.13 | $19.25 | 2023-10-11 - 2024-04-25 | Buy |
Edgewise Therapeutics IncEWTX | +189.29% | $5.51 | $15.94 | 2023-11-09 - 2024-04-25 | Buy |
Ardelyx IncARDX | +144.50% | $3.82 | $9.34 | 2023-03-02 - 2024-03-01 | Buy |
Edgewise Therapeutics IncEWTX | +137.56% | $6.71 | $15.94 | 2023-08-10 - 2024-04-25 | Buy |
Edgewise Therapeutics IncEWTX | +120.47% | $7.23 | $15.94 | 2023-08-15 - 2024-04-25 | Buy |
Laura Chico Analyst Color
Get additional color on Laura Chico's coverage of popular stocks
Laura Chico's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biogen IncBIIB | 12 | Hold | $215.00 | +6.19% | Maintains | 2 days ago |
Travere Therapeutics IncTVTX | 7 | Buy | $13.00 | +141.19% | Reiterates | 9 days ago |
Sage Therapeutics IncSAGE | 5 | Hold | $24.00 | +76.73% | Reiterates | 9 days ago |
Ultragenyx Pharmaceutical IncRARE | 7 | Hold | $48.00 | +9.46% | Reiterates | 9 days ago |
Neurocrine Biosciences IncNBIX | 6 | Buy | $147.00 | +6.71% | Reiterates | 9 days ago |
Ardelyx IncARDX | 9 | Buy | $14.00 | +121.87% | Maintains | 9 days ago |
Apellis Pharmaceuticals IncAPLS | 11 | Hold | $57.00 | +18.92% | Maintains | 9 days ago |
Edgewise Therapeutics IncEWTX | 6 | Buy | $26.00 | +63.11% | Reiterates | 10 days ago |
Rallybio CorpRLYB | 4 | Buy | $11.00 | +566.67% | Maintains | 15 days ago |
Pharvaris NvPHVS | 4 | Buy | $35.00 | +53.71% | Reiterates | 15 days ago |
Gossamer Bio IncGOSS | 1 | Buy | $4.00 | +497.01% | Assumes | 22 days ago |
Ovid Therapeutics IncOVID | 1 | Buy | $8.00 | +167.56% | Initiates Coverage On | 22 days ago |
Stoke Therapeutics IncSTOK | 5 | Buy | $17.00 | +45.42% | Maintains | a month ago |
Dianthus Therapeutics IncDNTH | 3 | Buy | $33.00 | +57.22% | Maintains | a month ago |
Vera Therapeutics IncVERA | 6 | Hold | $34.00 | -12.12% | Maintains | a month ago |
Design Therapeutics IncDSGN | 5 | Hold | $5.00 | +32.98% | Reiterates | a month ago |
Longboard Pharmaceuticals IncLBPH | 4 | Buy | $32.00 | +66.23% | Reiterates | a month ago |
Pepgen IncPEPG | 6 | Buy | $20.00 | +70.94% | Maintains | 2 months ago |
Astria Therapeutics IncATXS | 6 | Buy | $17.00 | +85.39% | Reiterates | 2 months ago |
Xenon Pharmaceuticals IncXENE | 6 | Buy | $51.00 | +27.18% | Maintains | 2 months ago |
Viridian Therapeutics IncVRDN | 6 | Buy | $40.00 | +214.96% | Maintains | 2 months ago |
Denali Therapeutics IncDNLI | 5 | Buy | $31.00 | +107.22% | Reiterates | 2 months ago |
Praxis Precision Medicines IncPRAX | 5 | Hold | $29.00 | -45.16% | Maintains | 3 months ago |
Karuna Therapeutics IncKRTX | 4 | Hold | $330.00 | +0.05% | Downgrades | 4 months ago |
Vigil Neuroscience IncVIGL | 4 | Buy | $23.00 | +791.47% | Reiterates | 5 months ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $42.00 | +3.99% | Downgrades | 9 months ago |
Impel Pharmaceuticals IncIMPLQ | 2 | Hold | $5.00 | N/A | Downgrades | a year ago |
Taysha Gene Therapies IncTSHA | 2 | Buy | $5.00 | N/A | Maintains | 2 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $148.50 | N/A | Downgrades | 2 years ago |
Viela Bio IncVIE | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Voyager Therapeutics IncVYGR | 1 | Hold | $6.00 | N/A | Downgrades | 3 years ago |
Biomarin Pharmaceutical IncBMRN | 3 | Buy | $110.00 | N/A | Reinstates | 5 years ago |
Acer Therapeutics IncACER | 2 | Buy | $40.00 | N/A | Reinstates | 5 years ago |
Paratek Pharmaceuticals IncPRTK | 2 | Buy | N/A | N/A | Downgrades | 6 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $720.00 | N/A | Initiates Coverage On | 6 years ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.